Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb:163:156099.
doi: 10.1016/j.metabol.2024.156099. Epub 2024 Dec 10.

Serotonin neurons integrate GABA and dopamine inputs to regulate meal initiation

Affiliations

Serotonin neurons integrate GABA and dopamine inputs to regulate meal initiation

Kristine M Conde et al. Metabolism. 2025 Feb.

Abstract

Obesity is a growing global health epidemic with limited orally administered therapeutics. Serotonin (5-HT) is one neurotransmitter which remains an excellent target for new weight-loss therapies, but a gap remains in understanding the mechanisms involved in 5-HT produced in the dorsal Raphe nucleus (DRN) and its involvement in meal initiation. Using an optogenetic feeding paradigm, we showed that the 5-HTDRN➔arcuate nucleus (ARH) circuit plays a role in meal initiation. Incorporating electrophysiology and ChannelRhodopsin-2-Assisted Circuit Mapping, we demonstrated that 5-HTDRN neurons receive inhibitory input partially from GABAergic neurons in the DRN, and the 5-HT response can be enhanced by hunger. Additionally, deletion of the GABAA receptor subunit in 5-HT neurons inhibits meal initiation with no effect on the satiation process. Finally, we identified the role of dopaminergic inputs via dopamine receptor D2 in enhancing the response to GABA-induced feeding. Thus, our results indicate that 5-HTDRN neurons are inhibited by synergistic inhibitory actions of GABA and dopamine, for the initiation of a meal.

Keywords: Dopamine; GABA; Meal initiation; Serotonin.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1:
Fig. 1:. The 5-HTDRN→ARH circuit regulates meal initiation.
(A) Schematic of viral injection and optic fiber placement. (B) Schematic of blue light stimulation during food approaching. (C) Schematic of yellow light inhibition during food approaching. Results in fasted mice with blue light stimulation of the 5-HTDRN→ARH circuit during food approaching (left): (D) food intake, (E) food bouts, (F) entries to the food approach zone, (G) probability of food intake during food approaching, (H) latency to eat, (I) bout duration. Results in sated mice with yellow light inhibition of the 5-HTDRN→ARH circuit during food approach (right): (J) food intake, (K) food bouts, (L) entries to the food approach zone, (M) probability of food intake during food approaching, (N) latency to eat, (O) bout duration. Data were analyzed with a paired nonparametric Wilcoxon Test. Data are presented as mean ± SEM, n=11-13 male mice. p < 0.05 *, p < 0.01 **, p < 0.001 ***, p < 0.0001 ****.
Fig. 2:
Fig. 2:. GABA inhibition of 5-HTDRN neurons is regulated by hunger.
(A) Schematic representation of viral approach. (B) Schematic of optogenetic electrophysiology recording. (C-E) Representative evoked inhibitory post-synaptic current (eIPSC) traces. (F) Quantification of eIPSC frequency from C-E. (G) Quantification of eIPSC amplitude from C-E. (H-J) Representative miniature inhibitory post-synaptic current (mIPSC) traces. (K-L) mIPSC amplitude quantification of 5-HTDRN neurons from male (K) and female (L) mice in a fed, 24 h fasted and 24 h fasted followed by 2 h refeed (refed) state. Data were analyzed with a two-way ANOVA with post-hoc multiple comparisons. Data are presented as mean ± SEM. For F-G, n=9 cells from 4 male mice. For H-L, n=8-21 cells from 3-5 male and female mice. p < 0.05 *, p < 0.01 **, p < 0.001 ***, p < 0.0001 ****.
Fig. 3:
Fig. 3:. GABAergic actions in 5-HTDRN neurons regulate meal initiation.
(A) Representative image of cannula placement above the DRN. (B) Cumulative food intake results in control mice after saline or Muscimol DRN infusion. (C) Cumulative food intake results in TPH2DRNKO mice after saline or Muscimol DRN infusion. (D) Cumulative food intake results in control and TPH2DRNKO mice after saline or Muscimol DRN infusion. (E) Average daily food intake, (F) meal interval, (G) meal number, and (H) meal size in γ2TPH2KO mice and control littermates. Data were analyzed with a two-way ANOVA with post-hoc multiple comparisons, except (D) which was analyzed by two-sided unpaired t-test. Data are presented as mean ± SEM, (B) n=15 male mice, (C) n=8 male mice, (D-G) n=5-6 male mice. p < 0.05 *, p < 0.01 **, p < 0.001 ***, p < 0.0001 ****.
Fig. 4.
Fig. 4.. DRD2 enhances 5-HTDRN neuronal responses to GABAergic inputs.
mIPSC amplitude in control, DRD2TPH2KO, and DRD1TPH2KO (A) fed males and (B) fed females. (C) 24 h fasted males and (D) females. (E) Total food intake in control and DRD2TPH2KO male mice after saline or Muscimol DRN infusion. Control mIPSC amplitude is the same as presented in Fig. 2K-L. Control Muscimol response is the same as presented in Fig. 3B. Data were analyzed with a two-way ANOVA with post-hoc multiple comparisons. Data are presented as mean ± SEM, (A-D) n=8-21 cells from 3-5 male and female mice, (E) n=8-15 male mice. p < 0.05 *, p < 0.01 **, p < 0.001 ***, p < 0.0001 ****.

Update of

References

    1. Flier JS, Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337–350 (2004). - PubMed
    1. Correia ML, Rahmouni K, Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes Metab 8, 603–610 (2006). - PubMed
    1. Lechin F, van der Dijs B, Hernández-Adrián G, Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Prog Neuropsychopharmacol Biol Psychiatry 30, 565–585 (2006). - PubMed
    1. Rowland NE, Carlton J, Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27, 13–62 (1986). - PubMed
    1. Connolly HM et al. , Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337, 581–588 (1997). - PubMed

LinkOut - more resources